Literature DB >> 20371454

Pharmacologic induction of CD8+ T cell memory: better living through chemistry.

Luca Gattinoni1, Christopher A Klebanoff, Nicholas P Restifo.   

Abstract

The generation of a robust population of memory T cells is critical for effective vaccine and cell-based therapies to prevent and treat infectious diseases and cancer. A series of recent papers have established a new, cell-intrinsic approach in which small molecules target key metabolic and developmental pathways to enhance the formation and maintenance of highly functional CD8(+) memory T cells. These findings raise the exciting new possibility of using small molecules, many of which are already approved for human use, for the pharmacologic induction of immunologic memory.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20371454      PMCID: PMC3241001          DOI: 10.1126/scitranslmed.3000302

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  36 in total

1.  The precursors of memory: models and controversies.

Authors:  Rafi Ahmed; Michael J Bevan; Steven L Reiner; Douglas T Fearon
Journal:  Nat Rev Immunol       Date:  2009-08-14       Impact factor: 53.106

2.  Boosting our best shot.

Authors:  Charlotte Schubert
Journal:  Nat Med       Date:  2009-09       Impact factor: 53.440

3.  Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties.

Authors:  Rachel L Rutishauser; Gislâine A Martins; Sergey Kalachikov; Anmol Chandele; Ian A Parish; Eric Meffre; Joshy Jacob; Kathryn Calame; Susan M Kaech
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

4.  Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice.

Authors:  Jian Huang; Yi Zhang; Alexey Bersenev; W Timothy O'Brien; Wei Tong; Stephen G Emerson; Peter S Klein
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

Review 5.  The cunning little vixen: Foxo and the cycle of life and death.

Authors:  Stephen M Hedrick
Journal:  Nat Immunol       Date:  2009-08-23       Impact factor: 25.606

6.  A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy.

Authors:  Cameron J Turtle; Hillary M Swanson; Nobuharu Fujii; Elihu H Estey; Stanley R Riddell
Journal:  Immunity       Date:  2009-10-29       Impact factor: 31.745

7.  T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma.

Authors:  Qing Yu; Archna Sharma; Sun Young Oh; Hyung-Geun Moon; M Zulfiquer Hossain; Theresa M Salay; Karen E Leeds; Hansen Du; Beibei Wu; Marian L Waterman; Zhou Zhu; Jyoti Misra Sen
Journal:  Nat Immunol       Date:  2009-08-02       Impact factor: 25.606

8.  mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging.

Authors:  Rogerio M Castilho; Cristiane H Squarize; Lewis A Chodosh; Bart O Williams; J Silvio Gutkind
Journal:  Cell Stem Cell       Date:  2009-09-04       Impact factor: 24.633

9.  mTOR regulates memory CD8 T-cell differentiation.

Authors:  Koichi Araki; Alexandra P Turner; Virginia Oliva Shaffer; Shivaprakash Gangappa; Susanne A Keller; Martin F Bachmann; Christian P Larsen; Rafi Ahmed
Journal:  Nature       Date:  2009-06-21       Impact factor: 49.962

10.  Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells.

Authors:  Luca Gattinoni; Xiao-Song Zhong; Douglas C Palmer; Yun Ji; Christian S Hinrichs; Zhiya Yu; Claudia Wrzesinski; Andrea Boni; Lydie Cassard; Lindsay M Garvin; Chrystal M Paulos; Pawel Muranski; Nicholas P Restifo
Journal:  Nat Med       Date:  2009-06-14       Impact factor: 53.440

View more
  43 in total

Review 1.  Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.

Authors:  Luca Gattinoni; Yun Ji; Nicholas P Restifo
Journal:  Clin Cancer Res       Date:  2010-08-05       Impact factor: 12.531

Review 2.  Therapeutic cancer vaccines: are we there yet?

Authors:  Christopher A Klebanoff; Nicolas Acquavella; Zhiya Yu; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.

Authors:  Christian S Hinrichs; Zachary A Borman; Luca Gattinoni; Zhiya Yu; William R Burns; Jianping Huang; Christopher A Klebanoff; Laura A Johnson; Sid P Kerkar; Shicheng Yang; Pawel Muranski; Douglas C Palmer; Christopher D Scott; Richard A Morgan; Paul F Robbins; Steven A Rosenberg; Nicholas P Restifo
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

4.  Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.

Authors:  Madhusudhanan Sukumar; Jie Liu; Yun Ji; Murugan Subramanian; Joseph G Crompton; Zhiya Yu; Rahul Roychoudhuri; Douglas C Palmer; Pawel Muranski; Edward D Karoly; Robert P Mohney; Christopher A Klebanoff; Ashish Lal; Toren Finkel; Nicholas P Restifo; Luca Gattinoni
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

5.  A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.

Authors:  C Berger; M Berger; D Anderson; S R Riddell
Journal:  J Med Primatol       Date:  2010-11-02       Impact factor: 0.667

6.  T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules.

Authors:  Navtej Kaur; Osama S Naga; Håkan Norell; Amir A Al-Khami; Matthew J Scheffel; Nitya G Chakraborty; Christina Voelkel-Johnson; Bijay Mukherji; Shikhar Mehrotra
Journal:  Cytokine       Date:  2011-05-23       Impact factor: 3.861

Review 7.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 8.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 9.  Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?

Authors:  Christopher A Klebanoff; Luca Gattinoni; Nicholas P Restifo
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

10.  4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation.

Authors:  Beom K Choi; Do Y Lee; Don G Lee; Young H Kim; Seon-Hee Kim; Ho S Oh; Chungyong Han; Byoung S Kwon
Journal:  Cell Mol Immunol       Date:  2016-03-14       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.